Literature DB >> 8327083

Magnetic resonance imaging-directed stereotactic endoscopic third ventriculostomy.

R R Goodman1.   

Abstract

Third Ventriculostomy has been proposed as the procedure of choice for many patients with acquired obstructive hydrocephalus. Various techniques have been used to perform this procedure. This report describes the use of magnetic resonance images to guide the performance of a stereotactic third ventriculostomy with a rigid endoscope, allowing continuous direct visualization. This procedure has been performed on three patients, yielding clinical improvement without the need for extracranial shunting. Magnetic resonance imaging allows accurate identification of the important anatomical landmarks (i.e., foramen of Monro and interpeduncular cistern), with axial, coronal, and sagittal images, and is readily used in conjunction with the Cosman-Roberts-Wells stereotactic apparatus.

Entities:  

Mesh:

Year:  1993        PMID: 8327083     DOI: 10.1227/00006123-199306000-00031

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  A method of enlarging the opening of the third ventricular floor for flexible endoscopic third ventriculostomy.

Authors:  T T Wong; L S Lee
Journal:  Childs Nerv Syst       Date:  1996-07       Impact factor: 1.475

Review 2.  Microsurgical resection of pineal region tumors.

Authors:  Adam M Sonabend; Stephen Bowden; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2016-05-19       Impact factor: 4.130

Review 3.  Surgical strategies for treating patients with pineal region tumors.

Authors:  Jeffrey N Bruce; Alfred T Ogden
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

Review 4.  Endoscopic third ventriculostomy for obstructive hydrocephalus.

Authors:  Dieter Hellwig; Joachim Andreas Grotenhuis; Wuttipong Tirakotai; Thomas Riegel; Dirk Michael Schulte; Bernhard Ludwig Bauer; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2004-11-27       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.